Will Goodman practices in the firm’s Litigation Practice Group, primarily with the Life Sciences Industry Litigation and Food and Agriculture Litigation and Regulatory teams. Will is a nationally-recognized trial lawyer with experience in challenging venues throughout the United States. He has worked on major chemical exposure, class action, commercial, and pharmaceutical litigations, most of which involved hundreds or thousands of claims. Other significant matters include asbestos, dioxin, hearing loss, isocyanate, and toxic waste site/Superfund-related litigations.
Will's practice in recent years has focused on the national level defense of pharmaceutical and chemical companies in high stakes complex commercial and personal injury litigations. Will has been involved in over fifteen different mass tort pharmaceutical litigations. He has served as regional and trial counsel on national litigation involving genetically modified crops and in defense of a significant matter under the False Claims Act.
Admitted pro hac vice in many state and federal courts, Will has tried cases to verdict in Arkansas, California, and Mississippi. These trials included defense verdicts for Bayer in the second and third trials in the country involving the prescription medicine Baycol. Will also was selected for trial teams in cases that resolved before or during trial in Alabama, Arizona, Louisiana, Oklahoma, Pennsylvania, and Texas.